scorecardresearch
Follow Us:
Saturday, May 28, 2022

BioNTech

BIONTECH NEWS

‘Vaccines give extra protection to those with immunity from previous Covid infection’

April 01, 2022 11:44 am

Participants were selected from national disease surveillance and vaccination databases if they had a PCR confirmed SARS-CoV-2 reinfection, at least 90 days after they contracted the initial infection (22,566 people in total).

Pfizer-BioNTech seek US OK for second COVID booster for 65 and older

March 16, 2022 6:44 pm

Pfizer-BioNTech filed an application with US regulators seeking emergency use authorization for a second booster shot of their Covid-19 vaccine for people aged 65 and older.

US considers lengthening gap between first 2 Covid shots to 8 weeks

February 05, 2022 1:52 pm

In the United States, the recommended interval between the first two shots of Pfizer's vaccine is three weeks and for Moderna's, four.

Pfizer vaccine for children under 5 may be available in US by February end, says report

February 01, 2022 1:54 pm

Coronavirus vaccines for children younger than 5 could be available as soon as end-February under a plan that would lead to the potential authorisation of a two-shot regimen in the coming weeks.

Israel begins administering 4th vaccine dose

December 31, 2021 10:01 pm

The country will administer a fourth dose of the vaccine to individuals with weakened immune systems, along with elderly residents and employees in care homes.

Explained: What scientists have found about a class of antibodies that can neutralise the Omicron variant

December 30, 2021 7:58 pm

The antibodies identified by the scientists target areas of the virus spike protein that remain unchanged as it mutates.

Hong Kong researchers urge third Covid-19 shot after new Omicron study

December 15, 2021 11:28 am

This comes after a study showed insufficient antibodies were generated by the Sinovac and BioNTech products to fend off Omicron.

BioNTech starts work on Omicron-specific vaccine

November 29, 2021 8:19 pm

The development of an adapted vaccine is part of the company's standard procedure for new variants, BioNTech, which makes vaccines together with Pfizer, said in a statement.

Pfizer/BioNTech, Moderna expect data on shot's protection against new COVID-19 variant soon

November 27, 2021 11:30 am

🔴"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally," it added.

BioNTech says expect more data on new variant in 2 weeks

November 26, 2021 7:12 pm

🔴 Global authorities reacted with alarm on Friday to the new variant, with the EU and Britain among those tightening border controls as scientists sought to find out if the mutation was vaccine-resistant.

Advertisement
Advertisement
Advertisement